Ocugen, a biotechnology company focused on gene therapies for blindness, announced it will present its innovative modifier gene therapy platform at two upcoming conferences in November 2026: the Stifel Healthcare Conference in New York and the Cell & Gene Leaders Live event in London. The presentations will highlight Ocugen's gene-agnostic approach that targets multiple gene networks to address diseases like retinitis pigmentosa and age-related macular degeneration. This exposure aims to attract investor interest and industry partnerships as Ocugen advances its programs for inherited retinal diseases affecting millions worldwide. A webcast of the Stifel presentation will be available on Ocugen's investor website.
Ocugen's upcoming November investor and industry conferences provide context for readers interested in healthcare innovation. For readers following the health sector, here is Pluang's market snapshot as of Oct 29, 2026 17:11 WIB: out of 150 priced US health stocks tradable on Pluang, 86 rose and 57 fell. Notable movers include Butterfly Network Inc. Class A Common Stock (BFLY) at USD 8.32 with a 1-day change of +6.53%, Nuwellis Inc (NUWE) at USD 5.87 with +5.48%, and ClearPoint Neuro Inc (CLPT) at USD 11.00 with +4.17%.
Dimensional Fund Advisors Ltd. disclosed holding a 5.07% stake in Vesuvius PLC ordinary shares as of October 28, 2026. The disclosure follows regulatory requirements under the Takeover Code, indicating significant interest in the company. Dimensional...
Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...
Katapult Holdings, a technology-driven platform serving nonprime consumers, announced it will release its third quarter 2026 financial results on November 12, 2026, before the market opens. The company will hold a conference call and webcast at 8:00 ...
Lulu's Fashion Lounge Holdings, Inc. announced it will report its third quarter 2026 financial results on November 12, 2026, after market close. The company will host a live webcast and conference call for investors at 5:00 p.m. Eastern Time the same...
RadNet, Inc. announced it will hold a conference call on November 9, 2026, at 7:30 a.m. Pacific Time to discuss its third quarter financial results. Investors can join via phone or webcast, with a replay available afterward. This call provides insigh...
